Clinical & Oncology Testing

Each tumour has a unique genetic makeup, even amongst cancers of the same tissue type. Genomic testing can be used to analyse the DNA of your tumour and may identify the genetic mutations that are unique to your cancer.

Identifying the mutations in a patient’s cancer is the key to developing personalised treatments. Depending on the type of testing done, a comprehensive genomic analysis may provide information on potential therapeutics, development of resistant to treatments, prognosis, disease tracking, and may provide access to clinical trials or new treatments that were not available at the time of diagnosis.

We offer a wide range of testing options. As each patient’s case is unique, there is no “one size fits all” when it comes to testing. We encourage you to contact Genomics For Life regarding testing and pricing, and we can work with you and your oncologist/specialist, to determine what tests would benefit you.

Genomics For Life has one of the largest genetic testing options of any laboratory in Australia. Our testing range covers over 3,000 genes associated with a whole range of inherited disorders. Some common inherited disorders we test for include Cystic Fibrosis, Inherited Cancers, Wilson’s Disease, Noonan Syndrome, Stickler Syndrome and Ehlers-Danlos Syndrome.

The Pharmacogenomics test is your one test for life. The test will cover your metabolic response to medications at all stages in life, and can be referred back to at any time regardless of your age or health status. Pharmacogenomics is the analysis of how genes affect a person’s response to drugs. As everyone has a unique genetic makeup, this can affect how you will respond or react to certain medications. Through pharmacogenomics testing, individualised medicine treatment plans can be developed based on each patient’s genetic makeup, to determine optimal drugs and dosages, and limit harmful side effects.

NIFTY^TM is a highly accurate, Non-Invasive Prenatal Screening (NIPS) for chromosomal abnormalities. NIFTY^TM uses a blood sample from the pregnant mother to analyse the fetal DNA for chromosomal conditions including trisomies, such as Down Syndrome and Edwards Syndrome, Sex Chromosomal Aneuploidies and Deletion/Duplication Syndromes, from as early as 10 weeks,

Carrier screening is a valuable tool for prospective parents to help determine their risk of passing on a genetic condition to their children. Carriers of gene changes associated with inherited conditions have an increased risk of having a child affected with an inherited genetic condition. However, they may not be aware of their risk as they typically do not have any symptoms or health impacts. or may have no family history of genetic conditions.

Carrier screening prior to conception or in early pregnancy enables couples to learn about their reproductive risk and make properly informed reproductive decisions. It is recommended that carrier screening options are offered to all women when planning a pregnancy, regardless of their ethnicity or family history.

We offer a range of carrier screening options and can test for up to 420 genes associated with a range of common inherited diseases, including Cystic Fibrosis, Spinal Muscular Atrophy and Fragile X Syndrome. Our comprehensive and highly accurate testing allows prospective parents to make informed reproductive decisions in a timely manner.